PRE-SURGERY STATUS AND IN-HOSPITAL COMPLICATIONS OF CORONARY BYPASS GRAFTING IN PREDIABETES AND TYPE 2 DIABETES PATIENTS

Aim. Investigation of pre-operational status and the rate of in-hospital complications of coronary bypass surgery in patients with prediabetes comparing to diabetes type 2 (DM2) and normoglycemia.

Material and methods. Totally, 708 consecutive patients included, post coronary bypass grafting (CBG) in 2011-2012 in the SRI CICVS. If there was no established DM2 diagnosis, but borderline hyperglycemia had existed, patients underwent oral glucose tolerance test (GTT). Its results were interpreted in accordance with the recommended diagnostic criteria for DM2 and other glycemia disorders.

Results. Screening before the CBG made it to additionally reveal DM2 in 8,9% (n=63) of the investigated patients, prediabetes — in 10,4% (n=74). This increased the number of patients with established DM2 from 15,2% (n=108) to 24,1% (n=171), with prediabetes — from 3,0% (n=21) to 13,4% (n=95), overall number of persons with glucose metabolism disorder from 18,2% (n=129) to 37,5% (n=266). All participants were then selected to 3 groups by glycemia status: group 1 — no disorders (n=442), group 2 — prediabetes patients (n=95), group 3 — diabetes type 2 (n=171). In analysis of in-hospital complications, the following attracts an attention: in the prediabetes group, specifically, an urgent operation on lower limbs arteries was done more frequently comparing to two other groups (р₁₂=0,002 and р₁₃=0,023). Also, the highest rate of wound complications was in the prediabetes group (р₁ =0,012). There was clear trend of comparability of prediabetes and DM2 by the rate of in-hospital complications (odds ratio PR) 1,731, 95% confidence interval (CI) 1,131-2,626, р=0,012), longer hospitalization ^R 2,229, 95% CI 1,4123,519, р<0,001), risk of urgent operation on the lower extremities arteries (OR 1,638, 95% CI 1,009-15,213, р=0,020), multiorgan failure PR 2,911, 95% CI 1,072-7,901, р=0,039), and the need for extra-corporal hemostasis correction ^R 3,472, 95% CI 1,042-11,556, р=0,044). With addition of prediabetes to the regression model and regard of any glucose tolerance disorder as possible predictor of in-hospital complications, all the listed above remained significant, and there was additional relation of prediabetes and diabetes with the risk of acute kidney injury ^R 1,700, 95% CI 1,067-2,612, р=0,024) and wound complications PR 1,547 95% CI 1,0732,231, р=0,019).

Conclusion. Prediabetes is the same adverse as diabetes in its influence on inhospital prognosis of CBG, that underscores the importance of active preoperational screening of glucose intolerance.

1. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013; 34 (39): 3035-87.

2. Bezdenezhnykh NA, Sumin AN, Barbarash OL. Patients with diabetes and myocardial revascularization from evidence-based medicine positions: cardiologist's opinion. Part 1. Russian Journal of Cardiology. 2017; 4: 105-13. (In Russ.)

3. D'Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2016 Update on Outcomes and Quality. Ann Thorac Surg. 2016 Jan; 101 (1): 24-32. Epub 2015 Nov 24. DOI: 10.1016/j.athoracsur.2015.11.032.

4. Petursson P, Herlitz J, Lindqvist J, et al. Prevalence and severity of abnormal glucose regulation and its relation to long-term prognosis after coronary artery bypass grafting. Coron Artery Dis. 2013 Nov; 24 (7): 577-82.

5. Balakrishnan R, Berger JS, Tully L, et al. Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention. Diabetes/metabolism research and reviews. 2015; 31 (6): 603-9. DOI:10.1002/dmrr.2646.

6. Bezdenezhnykh NA, Sumin AN, Barbarash OL. Patients with diabetes and myocardial revascularization from evidence-based medicine positions: cardiologist's opinion. Part 2. Russian Journal of Cardiology. 2017; 5: 146-52. (In Russ.)

7. Huang D, Refaat M, Mohammedi K, et al. Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res Int. 2017; 2017: 7839101. DOI: 101155/2017/7839101.

8. Zheng J, Cheng J, Wang T, et al. Does HbA1c Level Have Clinical Implications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting? A Systematic Review and MetaAnalysis. Int J Endocrinol. 2017; 2017: 1537213. DOI: 101155/2017/1537213.

9. Bezdenezhnykh NA, Sumin AN, Bezdenezhnykh AV, Barbarash OL. Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus: A Cardiologist's View. In: Aronow WS editors. Coronary Artery Bypass Graft Surgery. RiJeca: InTech; 2017. p. 69-89. DOI: 10.5772/intechopen.70416.

10. Algorithms specialized medical care to patients with diabetes, 5 edition. Ed. Dedov II, Shestakova MV. Diabetes Mellitus. 2011; 14 (3s): 2-72. (In Russ.)

11. Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes Mellitus. 2016; 19 (2): 104-12. (In Russ.)

12. Kok MM, von Birgelen C, Sattar N, et al. Prediabetes and its Impact on Clinical Outcome After Coronary Intervention in a Broad Patient Population. EuroIntervention. 2018 Jan 9. pii: EIJ-D-17-01067 DOI: 10.4244/EIJ-D-17-01067 [Epub ahead of print].

13. Tabak AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. Lancet. 2012 Jun 16; 379 (9833): 2279-90. DOI: 101016/S01406736(12)60283-9.

14. Teplyakov AT, Grakova EV, Svarovskaya AV, et al. Efficacy of endovascular coronary revascularization in patients with CHD with reduced left ventricular. Complex Issues of Cardiovascular Diseases. 2017; 1: 79-91. (In Russ.)

15. Bezdenezhnykh NA, Sumin AN, Fedorova NV, et al. Cardio-ankle vascular index and its relation to type 2 diabetes and prediabetes according to research ESSE in the Kemerovo region of the Russian Federation. Arterial Hypertension. 2016; 22 (6): 571-83. (In Russ.)

16. Scicali R, Giral P, Gallo A, et al. HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients. Atherosclerosis. 2016 Dec; 255: 102-8. DOI: 10.1016/j.atherosclerosis.2016.11.003.